Iron-Cobalt Bimetallic Composite Catalysis for Activated Peroxyacetic Acid Degradation of Sulfamethoxazole

1. Definition and Fundamental Principles

The study of iron-cobalt bimetallic composite-activated peroxyacetic acid (PAA) systems for the degradation of sulfamethoxazole (SMX) represents an advanced application of bimetallic composite technology in environmental catalysis. Sulfamethoxazole, a widely used sulfonamide antibiotic, is a recalcitrant micropollutant found in pharmaceutical wastewater, municipal effluents, and surface waters at concentrations ranging from ng/L to μg/L. Its persistence in the environment poses significant risks of antibiotic resistance gene (ARG) dissemination and ecological toxicity.

The fundamental principle of this technology rests on the activation of peroxyacetic acid (CH₃COOOH) by iron-cobalt bimetallic composites to generate highly reactive hydroxyl radicals (·OH) and other reactive oxygen species (ROS), which non-selectively oxidize the SMX molecular structure to achieve mineralization. The iron-cobalt bimetallic composite serves as a heterogeneous Fenton-like catalyst, where the synergistic interaction between Fe and Co active sites lowers the activation energy required for PAA decomposition compared to monometallic catalysts.

1.1 Catalytic Mechanism

The catalytic degradation process involves several sequential and parallel reaction pathways:

Fe²⁺/Fe³⁺ Redox Cycle: Iron species in the bimetallic composite facilitate the homolytic cleavage of the O–O bond in PAA, producing ·OH radicals and acetate species.
Co²⁺/Co³⁺ Redox Cycle: Cobalt species participate in a complementary redox cycle, enhancing the overall radical generation rate and improving catalyst regeneration efficiency.
Bimetallic Synergistic Effect: The Fe–Co interaction creates electron-transfer pathways that prevent catalyst deactivation through oxidation state locking, maintaining continuous catalytic activity over extended reaction cycles.
Surface Adsorption and Activation: The bimetallic composite surface adsorbs both PAA and SMX molecules, concentrating reactants at catalytic active sites and reducing the diffusion-limited reaction rate.

1.2 Key Reaction Equations

Fe²⁺ + CH₃COOOH → Fe³⁺ + CH₃COO^· + ·OH

Co²⁺ + CH₃COOOH → Co³⁺ + CH₃COO^· + ·OH

Fe³⁺ + CH₃COO^· → Fe²⁺ + CH₃COO^· (catalyst regeneration)

SMX + ·OH → Intermediate degradation products → CO₂ + H₂O + SO₄²⁻ + NO₃⁻

2. Category and Business Positioning

This technology entry bridges Cladding Technology Shanxi Co., Ltd's core competency in bimetallic composite fabrication with an emerging environmental catalysis application domain. While the company's primary business routes focus on TIG/MIG weld overlay, hydraulic explosive bonding, and explosion welding for industrial cladding applications, this entry demonstrates the company's capability to extend bimetallic composite manufacturing into high-value-added functional materials for environmental remediation.

2.1 Strategic Positioning Within the Company Portfolio

Technology Extension: Leverages existing expertise in Fe-based and Co-based alloy fabrication to produce catalytic-grade bimetallic composites with controlled microstructure and surface chemistry.
Value Chain Upgrade: Moves beyond structural cladding (corrosion resistance, wear resistance) into functional composites (catalytic activity), commanding premium pricing and differentiated market positioning.
Qualification Enhancement: Demonstrates multidisciplinary technical capability spanning metallurgy, materials science, and environmental engineering, strengthening the company's profile for complex customer requirements.
R&D Credibility: Academic publication and study engagement establishes intellectual property foundation and supports future patent applications in catalytic composite materials.

2.2 Market Context

The global market for advanced oxidation process (AOP) catalysts is experiencing rapid growth driven by increasingly stringent pharmaceutical wastewater discharge standards (particularly under China's GB 21903-2008 and emerging pharmaceutical industry-specific discharge limits). Iron-cobalt bimetallic catalysts offer advantages over conventional homogeneous Fenton systems including reduced iron sludge generation, pH tolerance, recyclability, and enhanced catalytic efficiency at lower oxidant doses.

3. Technical Purpose and Value

3.1 Primary Technical Objectives

High Degradation Efficiency: Achieve >90% SMX removal within practical contact times (typically 15–60 minutes) under ambient temperature and near-neutral pH conditions.
Catalyst Stability: Maintain catalytic activity over multiple reuse cycles (≥10 cycles) with minimal leaching of Fe and Co ions into the treated water.
Low Oxidant Consumption: Optimize the PAA-to-catalyst ratio to minimize chemical consumption costs while maintaining effective radical generation.
Scalable Fabrication: Develop manufacturing processes that can produce catalytic composites at industrial scales (kg to ton level) with consistent performance characteristics.

3.2 Value Proposition

Environmental Compliance: Enables pharmaceutical manufacturers to meet or exceed regulatory SMX discharge limits (typically <1 μg/L for pharmaceutical effluent).
Cost Reduction: Heterogeneous catalysis eliminates the need for post-treatment iron sludge disposal, reducing total treatment costs by 30–50% compared to homogeneous Fenton processes.
Process Integration: PAA-activated systems can be integrated into existing wastewater treatment trains with minimal capital modification.
Technology Leadership: Positions the company as a pioneer in functional bimetallic composites for environmental applications, creating barriers to entry for competitors.

4. Key Process and Implementation Points

4.1 Catalyst Fabrication Parameters

Parameter	Optimal Range	Measurement Method	Performance Impact
Fe:Co Atomic Ratio	1:1 to 2:1	ICP-OES / XRF	Higher Fe content increases ·OH yield; higher Co content improves stability
Composite Particle Size	10–100 μm (powder) or monolithic	Laser diffraction / SEM	Smaller particles increase surface area; larger particles reduce filtration difficulty
Specific Surface Area (BET)	20–150 m²/g	N₂ adsorption-desorption	Directly correlates with available catalytic active sites
Crystalline Phase Composition	FeCo intermetallic + FeCo₃ + residual Fe	XRD	Intermetallic phases provide stable catalytic sites; residual Fe provides redox activity
Surface Oxidation State	Fe²⁺/Fe³⁺ ratio ≥ 0.5	XPS	Higher Fe²⁺ fraction accelerates initial PAA activation

4.2 Catalytic Reaction Conditions

Variable	Optimal Condition	Tolerance Range	Rationale
pH	3.0–7.0	2.0–8.0	FeCo composites maintain activity over wider pH range than monometallic Fe catalysts
PAA Concentration	0.5–2.0 mM	0.1–5.0 mM	Excess PAA causes radical scavenging; insufficient PAA limits oxidation capacity
Catalyst Loading	0.1–0.5 g/L	0.05–1.0 g/L	Diminishing returns above 0.5 g/L due to light/oxidant mass transfer limitations
SMX Initial Concentration	10–100 mg/L	1–500 mg/L	Higher concentrations require proportionally more PAA and catalyst
Temperature	25–40°C	15–50°C	Moderate temperature enhancement; excessive temperature promotes PAA thermal decomposition
Reaction Time	15–60 min	5–120 min	90% degradation typically achieved within 30 min under optimized conditions

4.3 Manufacturing Process Route Selection

The fabrication of iron-cobalt bimetallic composites for catalytic applications can leverage the company's three primary technology routes with distinct advantages:

4.3.1 TIG/MIG Weld Overlay Route

Application: Production of monolithic catalytic plates or structured packing elements for fixed-bed reactors.
Process: Fe-Co alloy wire (e.g., Fe-50Co or Fe-30Co-10Ni) deposited via TIG welding onto stainless steel substrate plates (304/316L) to create catalytic surfaces.
Advantages: Scalable to large plate dimensions; precise control over overlay thickness (0.5–3.0 mm); compatibility with existing welding infrastructure.
Key Considerations: Welding parameters must minimize dilution to maintain catalytic Fe:Co ratio; post-weld heat treatment (solution annealing at 800–900°C) may be required to achieve uniform intermetallic phase distribution.

4.3.2 Hydraulic Explosive Bonding (HydroExplosive Welding) Route

Application: Fabrication of Fe/Co composite panels for use as catalytic media in plate-and-frame reactor configurations.
Process: Water-jet-driven explosive bonding of iron and cobalt sheets at controlled collision velocities (200–400 m/s) to create metallurgically bonded interfaces with microstructural refinement.
Advantages: Excellent interfacial bonding quality; production of bulk composite materials with tailored layer configurations (e.g., Fe/Co/Fe/Co multilayers); no thermal dilution.
Key Considerations: Interface microstructure (wave amplitude, wavelength) affects catalytic surface area; post-bonding mechanical processing (milling, grinding) required to generate catalytic powder or structured elements.

4.3.3 Explosion Welding Route

Application: Large-scale production of Fe-Co composite plates for industrial-scale catalytic reactor construction.
Process: Conventional explosive welding using shaped charges to bond iron and cobalt sheets, followed by hot rolling or mechanical comminution to produce catalytic-grade composites.
Advantages: Highest throughput for bulk composite production; established process parameters; ability to produce composites with specific interfacial microstructures optimized for catalysis.
Key Considerations: Detonation velocity control critical for achieving optimal interface quality; safety and regulatory compliance required for explosive operations.

4.4 Performance Evaluation Protocol

Batch Reactor Testing: Evaluate SMX degradation efficiency, mineralization rate (TOC removal), and catalyst stability under controlled laboratory conditions.
Radical Identification: Employ electron paramagnetic resonance (EPR) with DMPO spin trapping and scavenger experiments (ethanol for ·OH, p-benzoquinone for superoxide) to confirm reactive species.
Intermediate Analysis: LC-MS/MS characterization of degradation intermediates to map the reaction pathway and assess toxicity reduction.
Reusability Testing: Conduct ≥10 consecutive catalytic cycles with catalyst recovery (magnetic separation or filtration) to evaluate activity retention.
Leaching Assessment: ICP-OES analysis of Fe and Co ion concentrations in treated water to ensure compliance with drinking water and discharge standards.

5. Applicable Standards and Acceptance Criteria

5.1 Environmental Standards

Standard	Relevance	Key Requirement
GB 21903-2008	Pharmaceutical wastewater discharge standard	Specific organic pollutant (SOP) control limits
GB 18918-2002	Urban wastewater treatment plant discharge standard	General effluent quality requirements
GB 5749-2022	Drinking water quality standard	Post-treatment water quality verification
GB/T 5750 series	Water quality analysis methods	Testing methodology for SMX, TOC, metal ions
HJ 828-2017	Wastewater - Determination of sulfonamides by LC-MS/MS	Quantitative analysis of sulfonamide antibiotics

5.2 Materials and Manufacturing Standards

Standard	Relevance	Key Requirement
GB/T 3375-2017	Terms and definitions for welded joints	Terminology for weld overlay processes
GB/T 11345-2013	Ultrasonic testing of welds	NDT for weld overlay interfaces
NB/T 47013 series	Pressure vessel NDT methods	Interface bonding quality verification
ASTM E1022	Standard test method for interfacial adhesion	Bond strength verification for explosive bonded composites
GB/T 6394-2017	Metallographic sample preparation	Microstructural characterization of composites

5.3 Acceptance Criteria for Catalytic Performance

SMX Removal Efficiency: ≥90% degradation within 30 minutes at pH 3–7, catalyst loading 0.3 g/L, PAA concentration 1.0 mM.
Mineralization Rate (TOC Removal): ≥60% within 60 minutes under optimized conditions.
Catalyst Reusability: Activity retention ≥80% after 10 consecutive cycles.
Metal Leaching: Fe leaching <0.5 mg/L; Co leaching <0.05 mg/L (compliant with GB 5749-2022 drinking water limits for cobalt at 0.05 mg/L).
Intermediate Toxicity: Degradation products must demonstrate reduced acute toxicity (EC₅₀ improvement ≥3-fold compared to parent SMX compound, verified via Vibrio fischeri bioluminescence assay per ISO 11348).

6. Common Risks and Controls

6.1 Technical Risks

Risk Category	Description	Mitigation Strategy
Catalyst Deactivation	Surface oxidation, poisoning by dissolved organic matter (DOM), or iron/cobalt leaching	Surface modification with carbon coating; periodic catalyst regeneration via acid washing (0.1 M HCl); addition of sacrificial reducing agents (H₂O₂ pulses)
Radical Scavenging	Excess PAA, bicarbonate, or chloride ions scavenge ·OH radicals	Optimize PAA dosing; pre-treat water to reduce ionic strength; select catalyst formulations tolerant of chloride
Incomplete Degradation	Formation of toxic intermediates (e.g., 5-nitroso-2-aminobenzoic acid from SMX)	Extend reaction time; increase oxidant dose; optimize pH to favor complete mineralization pathways
Composite Microstructure Variability	Inconsistent Fe:Co ratio or phase distribution between production batches	Implement strict raw material traceability; in-process XRF monitoring; statistical process control (SPC) on composition
Scale-Up Challenges	Laboratory performance not replicated in pilot or full-scale reactors	Conduct systematic scale-up studies (2L → 20L → 200L); CFD modeling of mass transfer; pilot-scale validation before commercial deployment

6.2 Safety and Regulatory Risks

PAA Handling: Peroxyacetic acid is a strong oxidizer requiring compliance with GB 15603-2022 (Hazardous chemicals classification) and local hazardous materials storage regulations. Storage temperature must be maintained below 30°C to prevent thermal decomposition.
Explosive Welding Operations: Strict compliance with GB 6722-2014 (Safety regulations for industrial explosion) and local public security bureau permits for explosive materials handling.
Cobalt Toxicity: Cobalt and its compounds are classified as hazardous (GBZ 2.1-2019 occupational exposure limits: TWA 0.05 mg/m³ for CoO). Engineering controls and PPE required during manufacturing.
Wastewater Discharge Compliance: Treated effluent must be verified against applicable discharge standards before release; continuous monitoring systems (CMS) may be required for pharmaceutical facilities.

6.3 Quality Control Measures

Incoming Material Inspection: ICP-OES verification of Fe and Co purity (≥99.5%) in raw materials; spectroscopic analysis of PAA concentration and purity.
In-Process Monitoring: Real-time composition analysis (XRF) during welding; temperature and collision velocity monitoring during explosive bonding; dimensional and microstructural inspection at defined intervals.
Final Product Testing: Comprehensive characterization (XRD, SEM, BET, XPS, ICP-OES) and catalytic performance verification (batch degradation tests) for each production batch.
Batch Traceability: Maintain complete records linking raw material certificates, process parameters, and performance test results for each catalyst lot.

7. Application Scenarios Across Company Technology Routes

7.1 TIG/MIG Weld Overlay Applications

Structured Catalytic Packings: Fe-Co overlay deposited on 304/316L stainless steel structured packing elements (Mellapak-type geometry) for use in packed-bed AOP reactors. The overlay provides catalytic activity while the stainless steel substrate ensures mechanical integrity and corrosion resistance in acidic operating conditions.
Immobilized Catalyst Plates: Weld overlay of Fe-Co alloy on perforated plate substrates to create fixed-bed catalytic elements for continuous-flow treatment systems. Overlay thickness of 1.0–2.0 mm provides sufficient catalytic inventory for continuous operation.
Repair and Retrofit: Application to existing reactor internals to add catalytic functionality without complete equipment replacement, minimizing downtime and capital expenditure.

7.2 Hydraulic Explosive Bonding Applications

Fe/Co Multilayer Composite Panels: HydroExplosive welding of alternating Fe and Co sheets (0.5–2.0 mm each) to create bulk composites that are subsequently mechanically processed into catalytic granules or structured elements. The high-energy bonding process creates refined microstructures at interfaces with enhanced catalytic activity.
Functionally Graded Catalyst Supports: Multi-layer configurations (e.g., Co/Fe/FeCo/Fe/Co) to create catalyst elements with controlled composition gradients, optimizing both catalytic activity (surface layers) and structural integrity (core layers).
Porous Catalytic Monoliths: HydroExplosive bonded Fe-Co composites with subsequent controlled porosity development (acid etching or selective leaching) to create high-surface-area catalytic monoliths for plug-flow reactor applications.

7.3 Explosion Welding Applications

Bulk Composite Production: Industrial-scale explosive welding of Fe and Co sheets (up to 2000 mm × 1000 mm) followed by hot rolling and mechanical comminution to produce catalytic powder at ton-level quantities. This route offers the highest throughput for commercial-scale catalyst supply.
Large-Diameter Reactor Linings: Explosion welding of Fe-Co composite cladding onto reactor vessel interiors to create catalytic reactor walls that simultaneously provide structural containment and catalytic functionality, eliminating the need for separate catalyst containment elements.
Custom Geometric Elements: Production of explosion-welded Fe-Co composite sheets that are subsequently formed into custom geometries (tubes, cones, spiral elements) for specialized reactor configurations.

8. Qualification Building and Customer Value

8.1 Qualification and Certification Enhancement

Technical Qualification: Successful development and demonstration of catalytic bimetallic composites establishes the company's capability in functional materials engineering, complementing existing structural cladding qualifications. This supports qualification for advanced manufacturing contracts requiring multidisciplinary expertise.
WPS/PQR Extension: Welding procedure specifications developed for Fe-Co overlay applications can be extended to similar alloy systems (Fe-Ni, Fe-Co-Ni, Fe-Mn), broadening the company's procedural qualification portfolio.
Environmental Compliance Certification: Demonstrated capability in pharmaceutical wastewater treatment catalysts supports the company's eligibility for environmental technology certifications and green manufacturing credentials.
Intellectual Property Foundation: Research findings from this study provide the technical basis for patent applications covering catalyst compositions, manufacturing processes, and reactor configurations.

8.2 Customer Value Delivery

Turnkey Catalyst Solutions: Provide customers with complete catalytic systems including custom-fabricated Fe-Co composite elements, optimized reaction parameters, and performance guarantees, reducing customer development risk and time-to-market.
Performance-Based Contracts: Offer guaranteed SMX removal efficiency (≥90%) with catalyst replacement schedules, aligning company interests with customer operational outcomes.
Customization Capability: Tailor Fe:Co ratio, particle size, surface area, and geometry to match specific customer wastewater characteristics (SMX concentration, co-pollutants, pH, temperature, flow rate).
Lifecycle Cost Reduction: Deliver total cost of ownership advantages through extended catalyst life (≥12 months continuous operation), reduced sludge generation, and minimized energy consumption compared to alternative AOP technologies.
Regulatory Risk Mitigation: Help pharmaceutical manufacturers achieve compliance with evolving SMX discharge limits, avoiding potential penalties and production shutdowns.

8.3 Technology Roadmap Integration

Phase 1 (Current): Laboratory-scale validation of Fe-Co composite catalysts for SMX degradation; optimization of composition and reaction conditions; publication of study findings.
Phase 2 (12–18 months): Pilot-scale demonstration (50–500 L reactor) with real pharmaceutical wastewater; catalyst durability testing; process integration studies with existing treatment trains.
Phase 3 (18–24 months): Full-scale commercial deployment at pharmaceutical facilities; establishment of catalyst manufacturing production line; development of standardized product catalog.
Phase 4 (24–36 months): Technology extension to other recalcitrant micropollutants (tetracycline, ciprofloxacin, bisphenol A); development of multi-catalyst systems for comprehensive pharmaceutical wastewater treatment.

9. Conclusion

The study of iron-cobalt bimetallic composite-activated peroxyacetic acid systems for sulfamethoxazole degradation represents a strategic technology extension for Cladding Technology Shanxi Co., Ltd. By leveraging core competencies in bimetallic composite fabrication—across TIG/MIG weld overlay, hydraulic explosive bonding, and explosion welding routes—the company can deliver high-performance catalytic materials for an environmentally critical application. This capability not only generates new revenue streams in the environmental remediation sector but also strengthens the company's technical qualification portfolio, enhances customer relationships through value-added services, and positions the organization at the forefront of functional bimetallic materials development. The systematic approach to catalyst design, manufacturing, performance validation, and scale-up ensures reliable technology transfer from laboratory research to industrial deployment, creating measurable customer value through pharmaceutical wastewater compliance, operational cost reduction, and environmental risk mitigation.